ABVC BioPharma Inc

NASDAQ:ABVC  
2.97
-0.01 (-0.34%)
Earnings Announcements

Abvc Biopharma Reports Qtrly Net Loss Per Share, Basic And Diluted $0.07

Published: 11/15/2021 22:43 GMT
ABVC BioPharma Inc (ABVC) - Abvc Biopharma Reports Third Quarter 2021 Financial and Operational Results.
Abvc Biopharma Inc - Qtrly Net Loss per Share, Basic and Diluted $0.07.
Revenue is expected to be $0.2 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.